article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients ā€” and especially the pharma companies that promote them ā€” but a wrong long-term value for healthcare costs.

article thumbnail

Can J&Jā€™s vaccine approval erase bad pharma?

World of DTC Marketing

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? billion in penalties.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How pharma companies and governments can overcome COVID-19 vaccine hesitancy

BioPharma Reporter

While governments are now getting ready to ensure large-scale, equitable access and distribution of a COVID-19 vaccine, concern about vaccine hesitancy is growing worldwide. The COVID-19 pandemic is expected to continue to impose enormous burdens on societies and economies globally.

article thumbnail

Large pharma companies support Women in STEM leadership pilotĀ 

Drug Discovery World

The participants represent varied areas of expertise, including data scientists, industry regulators, and drug safety and development researchers; 45% are based in the US, and the remaining 55% span Europe and China. . The post Large pharma companies support Women in STEM leadership pilot appeared first on Drug Discovery World (DDW).

article thumbnail

COVID-19 vaccine equity: Campaigners say onus on pharma companies to start sharing IP and to transfer technology

BioPharma Reporter

Rows about vaccine supply and threats of export blocks donĆ¢t do anything to bring us closer to ending the COVID-19 pandemic, say campaigners pushing for vaccine equity on a global level.

article thumbnail

GSKā€™s Maria Reyes Boceta-MuƱoz Talks Vaccine Development in a Post-Pandemic World

XTalks

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges youā€™re facing right now in vaccine development?

article thumbnail

GSK flags new data suggesting a stark decline in routine adult vaccinations in the US

BioPharma Reporter

The pharma company and the CDC are recommending that adults continue routine vaccination during the COVID-19 pandemic to reduce future vaccine-preventable disease (VPD) outbreaks and overall strain on the healthcare system.